It is now well established that the p53 gene, one of the first genes found to be frequently altered in gliomas, can be mutant in both IDH-wildtype and IDH-mutant glioblastomas [25], and therefore the detection of p53 mutations is diagnostically and prognostically not relevant [2]. This evidence concerns the gene IDH2 and glioma.